Cargando…

Clinical characteristics of pediatric patients with COVID-19 between Omicron era vs. pre-Omicron era

INTRODUCTION: Detailed data on clinical characteristics in children with the omicron strain of SARS-COV-2 are limited. METHODS: We conducted a retrospective observational study of children with COVID-19 at the National Center for Child Health and Development to evaluate the clinical manifestations d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iijima, Hiroyuki, Kubota, Mitsuru, Ogimi, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349025/ https://www.ncbi.nlm.nih.gov/pubmed/35933077 http://dx.doi.org/10.1016/j.jiac.2022.07.016

Ejemplares similares

Epiglottitis-Like Symptoms of COVID-19 in the Omicron Wave
por: Iijima, Hiroyuki, et al.
Publicado: (2022)

Clinical Characteristics of Post-COVID-19 Persistent Cough in the Omicron Era
por: Kang, Yu Ri, et al.
Publicado: (2023)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

International Evidence on Vaccines and the Mortality to Infections Ratio in the Pre-Omicron Era
por: Aizenman, Joshua, et al.
Publicado: (2023)

Persistent Symptoms After Acute COVID-19 Infection in Omicron Era
por: Jung, Young Hee, et al.
Publicado: (2022)

COVID-19 in a Pre-Omicron Era: A Cross-Sectional Immuno-Epidemical and Genomic Evaluation
por: Pagnossa, Jorge Pamplona, et al.
Publicado: (2023)

Characteristics of febrile seizures with SARS-CoV-2 infection in the Omicron era
por: Kim, Jee Min, et al.
Publicado: (2023)

291. Retrospective Study on Bacteremia in COVID-19 Patients in the Delta and Omicron Era
por: Park, Sunghee, et al.
Publicado: (2022)

Green Tea Consumption and the COVID-19 Omicron Pandemic Era: Pharmacology and Epidemiology
por: Storozhuk, Maksim, et al.
Publicado: (2023)

416. Poor clinical outcomes of COVID-19 patients receiving rituximab during the Omicron era
por: Lee, Chan Mi, et al.
Publicado: (2023)

Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group
por: Gandolfini, Ilaria, et al.
Publicado: (2022)

OHCA epidemiology in the era of the Omicron variant: Insights from Shanghai
por: Daya, Mohamud R., et al.
Publicado: (2023)

Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
por: Chen, Benjamin, et al.
Publicado: (2023)

Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies
por: Buonsenso, Danilo, et al.
Publicado: (2023)

Resurgence of Influenza Circulation in the Russian Federation during the Delta and Omicron COVID-19 Era
por: Sominina, Anna, et al.
Publicado: (2022)

Addressing the mental health of children in quarantine with COVID-19 during the Omicron variant era
por: Yuan, Ti-Fei, et al.
Publicado: (2023)

Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
por: Ren, Zuning, et al.
Publicado: (2023)

The Principles of SARS-CoV-2 Intervariant Competition Are Exemplified in the Pre-Omicron Era of the Colombian Epidemic
por: Orf, Gregory S., et al.
Publicado: (2023)

Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
por: Ntanasis-Stathopoulos, Ioannis, et al.
Publicado: (2023)

Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
por: Niemann, Carsten U., et al.
Publicado: (2022)

Euphorbia neriifolia Leaf Juice on Mild and Moderate COVID-19 Patients: Implications in OMICRON Era
por: Pramanik, Md Enayet Ali, et al.
Publicado: (2022)

107. Development of novel RT-PCR assay for detection of COVID-19 in the Post-Omicron Era
por: Moon, Jung Joo, et al.
Publicado: (2022)

Real-World COVID-19 Vaccine Protection Rates against Infection in the Delta and Omicron Eras
por: Zhu, Yuru, et al.
Publicado: (2023)

Posttraumatic stress disorder symptoms among healthcare workers during the Omicron era
por: Yin, YuanYuan, et al.
Publicado: (2023)

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
por: Abdelrahim, Maen, et al.
Publicado: (2022)

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
por: McCreary, Erin K, et al.
Publicado: (2022)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

PB1969: PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND CORONAVIRUS DISEASE 2019 IN THE OMICRON ERA
por: Qi, Feiyang, et al.
Publicado: (2023)

LB1577. Outcomes of Pregnant Women Exposed to Sotrovimab for the Treatment of COVID-19 in the Omicron Predominant Era (PRESTO)
por: Tuan, Jessica, et al.
Publicado: (2022)

Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)
por: Tuan, Jessica J., et al.
Publicado: (2023)

COVID-19 Burden in Long-Term Care Facilities in the Omicron Era: Public Health Action Not Yet Redundant
por: Krystallaki, Dimitra, et al.
Publicado: (2023)

Prevalence of Pneumonia Among Patients Who Died with COVID-19 Infection in Ancestral Versus Omicron Variant Eras
por: Hammer, Mark M., et al.
Publicado: (2023)

(583) Sotrovimab in Heart Transplant Recipients with Covid-19 in the Omicron Era: A National Transplant Center Experience
por: Garcia, C.N. Perez, et al.
Publicado: (2023)

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
por: Paybast, Sepideh, et al.
Publicado: (2022)

Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis
por: Ismail, Nabihah Farhana, et al.
Publicado: (2023)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
por: Rössler, Annika, et al.
Publicado: (2022)

Public Interest in COVID-19 Therapeutics for High-Risk Populations During the Omicron Era: A Google Trends Analysis
por: Degirmenci, Huseyin Berk, et al.
Publicado: (2022)

Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era
por: Chaiyakulsil, Chanapai, et al.
Publicado: (2023)

Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023)

Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era
por: Barnard, Rosanna C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u1n431hhdhrm2aknq2ujugu24s